CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico
Summary
GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Mexico. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Mexico. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Mexico, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Boehringer Ingelheim, Bayer, Pfizer, GSK, and Genomma Lab) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche Diagnostics, Essilor, Zimmer Biomet and Abbott)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Mexico
- Porter’s five forces analysis for pharmaceutical and medical devices market of Mexico
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Mexican healthcare market.
Reasons to buyThis report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Mexican healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Mexican healthcare market.
- Executive Summary
- Overview of Pharmaceutical Market
- Overview of Medical Device Market
- Deals Analysis
- Porter’s Five Forces Model
- Market Access
- Country Healthcare Landscape
- Opportunities and Challenges
- Appendix
- List of Tables
- Table 1: Ophthalmic Devices Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2015
- Table 2: Orthopedic Devices Market, Mexico, Revenue ($m) and Market Share (%) of Major Companies, 2018
- Table 3: Hospital Supplies Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2017
- Table 4: In Vitro Diagnostics Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2018
- Table 5: General Surgery Devices Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2018
- Table 6: Approval Timelines, Mexico, 2019
- Table 7: Medical Device Classification, Mexico, 2018
- Table 8: Approval Process, Mexico, 2018
- Table 9: Patent Fees, Mexico, 2019
- Table 10: Trade Fairs, Mexico, 2019
- List of Figures
- Figure 1: Pharmaceutical Market, Mexico, Revenue ($B), 2010-2017
- Figure 2: Medical Device Market, Mexico, Revenue ($B), 2015-2020
- Figure 3: Country Profile, Mexico, 2018
- Figure 4: Pharmaceutical Market, Mexico, Revenue ($B), 2010-2017
- Figure 5: Pharmaceutical Market, Mexico, Revenue Forecast ($B), 2018-2022
- Figure 6: Pharmaceutical Exports ($B), Mexico, 2010-2018
- Figure 7: Top Export Partners, Mexico, 2018
- Figure 8: Pharmaceutical Imports ($B), Mexico, 2010-2018
- Figure 9: Top Import Partners, Mexico, 2018
- Figure 10: Pharmaceutical Supply Chain, Mexico, 2019
- Figure 11: Major Health Services (%), Mexico, 2016
- Figure 12: Pharmaceutical Market, Major Players, 2017
- Figure 13: Medical Device Market, Mexico, Revenue ($B), 2015-2020
- Figure 14: Medical Device Market, Mexico, Revenue Forecast ($B), 2021-2025
- Figure 15: Medical Device Market, Mexico, Revenue by Segment ($M), 2018
- Figure 16: Ophthalmic Devices Market, Mexico, Revenue ($M), 2015-2022
- Figure 17: Ophthalmic Devices Market, Mexico, Market Share of Major Players (%), 2015
- Figure 18: Orthopedic Devices Market, Mexico, Revenue ($M), 2015-2022
- Figure 19: Orthopedic Devices Market, Mexico, Market Share of Major Companies (%), 2018
- Figure 20: Hospital Supplies Market, Mexico, Revenue ($M), 2015-2022
- Figure 21: Hospital Supplies Market, Mexico, Market Share of Major Players (%), 2017
- Figure 22: In Vitro Diagnostics Market, Mexico, Revenue ($M), 2015-2022
- Figure 23: In Vitro Diagnostics Market, Mexico, Market Share of Major Players (%), 2018
- Figure 24: General Surgery Devices Market, Mexico, Revenue ($M), 2015-2022
- Figure 25: General Surgery Devices Market, Mexico, Market Share of Major Players (%), 2018
- Figure 26: Diagnostic Market, Mexico, Revenue ($B), 2015-2020
- Figure 27: Diagnostic Market, Mexico, Revenue ($B), 2021-2025
- Figure 28: Medical Device Market, Mexico, Revenue ($B) of Major Companies, 2017
- Figure 29: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Mexico, 2018-2019
- Figure 30: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Mexico, 2018-2019
- Figure 31: M&A Deals by Therapy Area, Pharmaceutical Market, Mexico, 2018-2019(by value and by number)
- Figure 32: Medical Device Market Deals (by Deal Value and Deal Count, $M), Mexico, 2018
- Figure 33: Medical Device Market Deals, Top Therapy Area by Deal Value and Count , Mexico, 2018
- Figure 34: Medical Device Market Deals , (by Deal Value and Count), Mexico, 2018
- Figure 35: Medical Device Market Deals, Mexico, Venture Financing Deals by Therapy Area, 2018
- Figure 36: Organization of the Health System, Mexico, 2018
- Figure 37: Reimbursement Pricing for New Drugs, Mexico, 2018
- Figure 38: Out-of-Pocket Expenditure (% of total expenditure on health), Mexico, 2010-2016
- Figure 39: Annual Rate of Change (%), Health and Welfare Services Price Index, Mexico, 2012-2018
- Figure 40: Number of companies participating in CCNPMIS process and number of products negotiated, Mexico, 2008-2015
- Figure 41: Drug Registration Types and Data Requirements, Mexico, 2018
- Figure 42: Drug Approval Process, Mexico, 2018
- Figure 43: Patent Approval Timeline, Mexico, 2016
- Figure 44: Patent Approval Process, Mexico, 2016
- Figure 45: Trademark Process, Mexico, 2017
- Figure 46: Clinical Trial Regulations, Mexico, 2018
- Figure 47: Advertising Regulations, Mexico, 2018
- Figure 48: Hospitals (number), Mexico, 2010-2017
- Figure 49: Hospitals by Type (number), Mexico, 2010-2017
- Figure 50: Diagnostic Equipment (units per million population), Mexico, 2010-2017
- Figure 51: Hospital Beds (per 1,000 population), Mexico, 2010-2017
- Figure 52: Acute Care Hospital Beds (per 1,000 population), Mexico, 2010-2017
- Figure 53: Psychiatric Care Hospital Beds (per 1,000 population), Mexico, 2010-2017
- Figure 54: Life Expectancy (in years), Mexico, 2010-2017
- Figure 55: Immunization Rate (%), Mexico, 2010-2017
- Figure 56: PM2.5 (μg per m3), Mexico, 2010-2017
- Figure 57: CO2 Emissions (metric tons per capita), Mexico, 2010-2017
- Figure 58: Physicians (per 1,000 population), Mexico, 2010-2017
- Figure 59: Nurses (per 1,000 population), Mexico, 2010-2017
- Figure 60: Dentists, (per 1,000 population), Mexico, 2010-2017
- Figure 61: Major Causes of Mortality (Number of deaths), Mexico, 2016
- Figure 62: Major Causes of Male Mortality (Number of deaths), Mexico, 2016
- Figure 63: Major Causes of Female Mortality (Number of deaths), Mexico, 2016
- Figure 64: Disability-Adjusted Life Years by Major Disease (‘000), Mexico, 2016
- Figure 65: Healthcare Expenditure as Percentage of GDP (%), Mexico, 2010-2017
- Figure 66: Health Expenditure Share (% of total health spending), Mexico, 2010-2017
- Figure 67: Healthcare spending as per providers (%), Mexico, 2016
- Figure 68: Pharmaceutical Spending (% of total health spending), Mexico, 2011-2016
- Figure 69: Opportunities & Challenges, Mexico